These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3043185)

  • 1. Systematic binding analysis of the insulin gene transcription control region: insulin and immunoglobulin enhancers utilize similar transactivators.
    Moss LG; Moss JB; Rutter WJ
    Mol Cell Biol; 1988 Jun; 8(6):2620-7. PubMed ID: 3043185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pi, a pre-B-cell-specific enhancer element in the immunoglobulin heavy-chain enhancer.
    Libermann TA; Baltimore D
    Mol Cell Biol; 1993 Oct; 13(10):5957-69. PubMed ID: 8413200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pan basic helix-loop-helix proteins are required for insulin gene expression.
    Vierra CA; Nelson C
    Mol Endocrinol; 1995 Jan; 9(1):64-71. PubMed ID: 7760851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta-cell-specific protein binds to the two major regulatory sequences of the insulin gene enhancer.
    Ohlsson H; Karlsson O; Edlund T
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4228-31. PubMed ID: 3288987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence.
    Whelan J; Cordle SR; Henderson E; Weil PA; Stein R
    Mol Cell Biol; 1990 Apr; 10(4):1564-72. PubMed ID: 2181278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer.
    German MS; Blanar MA; Nelson C; Moss LG; Rutter WJ
    Mol Endocrinol; 1991 Feb; 5(2):292-9. PubMed ID: 1710033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin enhancer binding site 2 (IEB2; FAR) box of the insulin gene regulatory region binds at least three factors that can be distinguished by their DNA binding characteristics.
    Read ML; Smith SB; Docherty K
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):231-6. PubMed ID: 7619061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice.
    Annweiler A; Müller U; Wirth T
    Nucleic Acids Res; 1992 Apr; 20(7):1503-9. PubMed ID: 1579442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements.
    Satyamoorthy K; Park K; Atchison ML; Howe CC
    Mol Cell Biol; 1993 Nov; 13(11):6621-8. PubMed ID: 8413258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development.
    Jacobs Y; Vierra C; Nelson C
    Mol Cell Biol; 1993 Dec; 13(12):7321-33. PubMed ID: 8246953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors recognizing overlapping C1-A2 binding sites positively regulate insulin gene expression.
    Harrington RH; Sharma A
    J Biol Chem; 2001 Jan; 276(1):104-13. PubMed ID: 11024035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction.
    Artandi SE; Cooper C; Shrivastava A; Calame K
    Mol Cell Biol; 1994 Dec; 14(12):7704-16. PubMed ID: 7969114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer.
    Yutzey KE; Konieczny SF
    Nucleic Acids Res; 1992 Oct; 20(19):5105-13. PubMed ID: 1329039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.
    Beckmann H; Su LK; Kadesch T
    Genes Dev; 1990 Feb; 4(2):167-79. PubMed ID: 2338243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin gene expression in nonexpressing cells appears to be regulated by multiple distinct negative-acting control elements.
    Cordle SR; Whelan J; Henderson E; Masuoka H; Weil PA; Stein R
    Mol Cell Biol; 1991 May; 11(5):2881-6. PubMed ID: 2017182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements.
    Peleg S; Abruzzese RV; Cote GJ; Gagel RF
    Mol Endocrinol; 1990 Nov; 4(11):1750-7. PubMed ID: 2280775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl-1-like, and alpha-CBF-like transcription factors.
    Vallejo M; Penchuk L; Habener JF
    J Biol Chem; 1992 Jun; 267(18):12876-84. PubMed ID: 1352292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
    Elmaleh N; Matthias P; Schaffner W
    Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.